Back to search results

Study of Xtressé Gummy Supplement for Hair Loss in Men

This study is looking for men aged 18-65 with a specific type of hair loss (androgenic alopecia, or male pattern baldness) to test a new gummy supplement called Xtressé Hair Growth Gummies. These gummies contain a special blend of plant extracts and regenerative compounds. The goal is to see if taking two gummies daily for six months can safely and effectively improve hair growth, thickness, and density. Researchers will use special photographic analysis to measure changes in your hair and will also ask about your satisfaction. They will also monitor for any side effects. The study plans to enroll 40 participants, but its current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 40 male participants. It will evaluate the effects of Xtressé Hair Growth Gummies.
What's involved
You would have three visits over six months, receiving a 90-day supply of gummies at the first two visits. You'll take the gummies daily, keep a treatment diary, and have photographs and scalp analysis done at each visit.
Compensation
Not stated in the trial record.
Follow-up
Your hair density and thickness will be measured from enrollment to the end of treatment at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07637071

Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia

Not Yet Recruiting
NAAges 18–65InterventionalTreatment
Restore Biologics Holdings, Inc. dba Xtressé
~40 participants
Updated 2026-06-10 on ClinicalTrials.gov
What's tested:Xtressé Hair Growth Gummies

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Within-subject increase in hair density assessed via Canfield HairMetrix® Phototrichogram Analysis
Measured over From enrollment to the end of treatment at 6 months
+2 more outcomes measured

Conditions

Androgenic Alopecia
Hair Loss/Baldness
Hair Thinning

Explore related trials

Male pattern alopecia

Where it's being run

2 sites across 1 states
Florida2

Study leadership

  • Melissa Y Rayner, MS · STUDY_DIRECTOR · Restore Biologics Holdings, Inc. dba Xtressé

Who to contact

Dr. Matt Leavitt, DO
[email protected]
321-594-6851
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Males aged 18-65
Norwood III to IV, vertex focused
Fitzpatrick skin type I to VI
Ability and willingness to comply with study protocol

Exclusion

Change in other hair treatments in 3 months prior to study enrollment.
Known uncontrolled health conditions.
History of hair or scalp disorders that could interfere with study results.
History of metabolic syndrome.

What this trial measures

  • Within-subject increase in hair density assessed via Canfield HairMetrix® Phototrichogram AnalysisFrom enrollment to the end of treatment at 6 months

    Quantitative hair measurements calculated by analyzing the participants digital images from baseline to 6 months of taking Xtressé™ Supplements. Measurements of density as measured hair per cm².

  • Within-subject increase in hair thickness assessed via Canfield HairMetrix® Phototrichogram AnalysisFrom enrollment to the end of treatment at 6 months

    Quantitative hair measurements calculated by analyzing the participants digital images from baseline to 6 months of taking Xtressé™ Supplements. Measurements of follicular unit vellus/terminal ratio.

  • Hair Density Changes measured by SOCAiFrom enrollment to the end of treatment at 6 months

    Images will be captured using the the SOCAi system at baseline and Days 90, and 180, to evaluate hair density changes.